Product Images Progesterone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Progesterone NDC 51407-981 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
51407-980-01OL - Progesterone 100 mg - Rev. 0325.jpg - 51407 980 01OL Progesterone 100 mg Rev. 0325

This text includes information about Progesterone Capsules with a dosage of 100mg micronized progesterone per capsule. It provides instructions on usage, storage, and precautions, such as keeping out of reach of children and protecting from moisture. The product should not be used by individuals allergic to peanuts. The packaging includes a link for obtaining patient information online. The product is marketed by GSMS, Inc. in Camarillo, California, USA.*
51407-981-01OL - Progesterone 200 mg - Rev. 0325.jpg - 51407 981 01OL Progesterone 200 mg Rev. 0325

Each capsule of NDC 51407-981-01 contains 200 mg of micronized progesterone. This medication is typically used as prescribed by the healthcare provider, with the specific dosage instructions provided in the package insert. It is important to carefully read the accompanying directions before use. Remember to store the capsules in a tightly-sealed, light-resistant container, away from moisture, and at a temperature between 20°C - 25°C (68°F - 77°F). This product should not be used if allergic to peanuts, and should be kept out of the reach of children. Pharmacists should provide patient information along with each dispensed package. More information can be accessed at https://gsms.us/.*
graph1 - figure01

This data appears to show a comparison between the effects of conjugated estrogens alone, conjugated estrogens plus micronized progesterone in a cyclical manner, and a placebo over a period of 36 months. The table indicates the number of patients (n) remaining in each group at intervals of 0, 12, 24, and 36 months. This information may be useful for evaluating the efficacy and tolerability of these medications over an extended period.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.